Civil Service Medical Benefit Rules Offer Gold Card Option
Thailand's civil service medical benefit rules are being revised to allow public servants to choose between government healthcare or the Gold Card program, with stakeholders backing the flexibility. The amendment also lets civil servants de
Patricia Mongkolvanich, director of the Comptroller General's Department, revealed that the department is advancing a draft amendment to the Civil Service Medical Welfare Decree, which has now completed the public hearing phase. Stakeholders largely support the proposed changes, which would move away from the current requirement that civil servants must use their civil service healthcare benefits first.
Under the new draft, civil servants will be allowed to voluntarily choose between civil service healthcare benefits and Gold Card coverage to increase flexibility and options. The amendment also allows civil servants to determine which family members receive benefits, with family members able to opt for alternative coverage such as Gold Card or social security if not granted benefits.
"If they don't want to use civil service benefits but prefer to use Gold Card benefits, that's an additional option for them, because in some cases Gold Card coverage may provide better benefits," Mongkolvanich said. "This reflects feedback from civil servants, and we're acting on it. The same applies to family member benefits—civil servants wanted to decide who receives benefits and who doesn't, because there have been actual cases where they didn't want to extend benefits to certain family members."
Regarding drug disbursement criteria, Mongkolvanich clarified that these are still under review with medical facilities and stakeholders, with no official enforcement date set—contrary to reports suggesting January 1, 2027. The criteria do not ban original-brand medications but rather establish a stepped protocol for prescribing drugs based on medical appropriateness. Doctors can still prescribe brand-name drugs if medically necessary or upon request.
Beneficiaries will not need to co-pay for all brand-name medications, only in cases where a generic equivalent with comparable therapeutic results is available as an alternative, or where the brand-name drug exceeds the department's reimbursement rate.
Mongkolvanich emphasized that the primary goal of this amendment is to remove barriers to benefit usage for civil servants, with budget savings as a secondary effect. "Many believe this amendment will significantly reduce civil service welfare costs, but I want to clarify that budget reduction is not the main focus. Achieving meaningful savings would require implementing multiple measures simultaneously. What's important here is that existing regulations create obstacles for ordinary civil servants, so we need to review and fix them."
